Cargando…

Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2–Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages

Mitocryptides are a novel family of endogenous neutrophil-activating peptides originating from various mitochondrial proteins. Mitocryptide-2 (MCT-2) is one of such neutrophil-activating peptides, and is produced as an N-formylated pentadecapeptide from mitochondrial cytochrome b. Although MCT-2 is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marutani, Takayuki, Nishino, Kodai, Miyaji, Tomoyuki, Kamada, Keisuke, Ohura, Koji, Kiso, Yoshiaki, Mukai, Hidehito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071274/ https://www.ncbi.nlm.nih.gov/pubmed/33920954 http://dx.doi.org/10.3390/ijms22084084

Ejemplares similares

FPR Ligands
por: Liu, Ying, et al.
Publicado: (2013)

Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2
por: Zhuang, Youwen, et al.
Publicado: (2022)

Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis
por: Ren, Tingting, et al.
Publicado: (2023)

N-Formylpeptides Induce Two Distinct Concentration Optima for Mouse Neutrophil Chemotaxis by Differential Interaction with Two N-Formylpeptide Receptor (Fpr) Subtypes: Molecular Characterization of Fpr2, a Second Mouse Neutrophil Fpr
por: Hartt, Jennifer K., et al.
Publicado: (1999)

The ambiguous role of FPR1 in immunity and inflammation
por: Vacchelli, Erika, et al.
Publicado: (2020)

FPR2: A Novel Promising Target for the Treatment of Influenza
por: Alessi, Marie-Christine, et al.
Publicado: (2017)

Decreased Placental FPR2 in Early Pregnancies That Later Developed Small-For-Gestation Age: A Potential Role of FPR2 in the Regulation of Epithelial-Mesenchymal Transition
por: Murthi, Padma, et al.
Publicado: (2020)

The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
por: Petri, Marcelo H., et al.
Publicado: (2015)

Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
por: Li, Anna, et al.
Publicado: (2020)

Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)

Microenvironment involved in FPR1 expression by human glioblastomas
por: Boer, J. C., et al.
Publicado: (2015)

FPR1 is the plague receptor on host immune cells
por: Osei-Owusu, Patrick, et al.
Publicado: (2019)

FPR2 Expression in Placental Extravillous Trophoblasts, and Its Relationship with Race, Delivery Mode, and Chorioamnionitis
por: Sweeney, Sarah, et al.
Publicado: (2022)

Neutrophil Infiltration of the Colon Is Independent of the FPR1 yet FPR1 Deficient Mice Show Differential Susceptibilities to Acute Versus Chronic Induced Colitis
por: Farooq, Shukkur M., et al.
Publicado: (2012)

ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland
por: Wang, Ching-Shuen, et al.
Publicado: (2016)

Structural basis of FPR2 in recognition of Aβ(42) and neuroprotection by humanin
por: Zhu, Ya, et al.
Publicado: (2022)

FPR1 mediates the tumorigenicity of human cervical cancer cells
por: Cao, Guangming, et al.
Publicado: (2018)

Application of small molecule FPR1 antagonists in the treatment of cancers
por: Ahmet, Djevdet S., et al.
Publicado: (2020)

Role of formyl peptide receptor 2 (FPR2) in the normal brain and in neurological conditions
por: Ong, Wei-Yi, et al.
Publicado: (2019)

A Pepducin Derived from the Third Intracellular Loop of FPR2 Is a Partial Agonist for Direct Activation of This Receptor in Neutrophils But a Full Agonist for Cross-Talk Triggered Reactivation of FPR2
por: Gabl, Michael, et al.
Publicado: (2014)

The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus
por: Rahman, Fryad, et al.
Publicado: (2018)

FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients
por: Hou, Xi-Lu, et al.
Publicado: (2017)

Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3
por: Wickstead, Edward S., et al.
Publicado: (2020)

Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction
por: Koenig, Andrew L., et al.
Publicado: (2021)

WKYMVm/FPR2 Alleviates Spinal Cord Injury by Attenuating the Inflammatory Response of Microglia
por: Zhang, Wenwu, et al.
Publicado: (2022)

Keratinocytes use FPR2 to detect Staphylococcus aureus and initiate antimicrobial skin defense
por: Lebtig, Marco, et al.
Publicado: (2023)

Distinct Signaling Cascades Elicited by Different Formyl Peptide Receptor 2 (FPR2) Agonists
por: Cattaneo, Fabio, et al.
Publicado: (2013)

The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis
por: Snapkov, Igor, et al.
Publicado: (2016)

Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer
por: Chen, Chen, et al.
Publicado: (2021)

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
por: Petrazzuolo, Adriana, et al.
Publicado: (2020)

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis
por: Le Naour, Julie, et al.
Publicado: (2023)

Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord
por: Zhu, Sipin, et al.
Publicado: (2022)

Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit Streptococcus agalactiae Infection
por: Sun, Zeyu, et al.
Publicado: (2021)

Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
por: Cai, Yongqing, et al.
Publicado: (2018)

Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing †
por: Gröper, Jieny, et al.
Publicado: (2020)

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
por: Sztupinszki, Zsofia, et al.
Publicado: (2021)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA
por: Cussell, Peter J. G., et al.
Publicado: (2019)

Lipoxin A(4) activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion
por: Hodges, Robin R., et al.
Publicado: (2016)

The G‐protein‐coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy
por: Yu, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8mslarenspui4ou62d77bc4bhb